Log in to save to my catalogue

Allogeneic hematopoietic stem cell transplantation for mucopolysaccharidosis patients: a single-cent...

Allogeneic hematopoietic stem cell transplantation for mucopolysaccharidosis patients: a single-cent...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ea00c93eae8b44a1bbe954d142586668

Allogeneic hematopoietic stem cell transplantation for mucopolysaccharidosis patients: a single-center experience and assessment of quality of life

About this item

Full title

Allogeneic hematopoietic stem cell transplantation for mucopolysaccharidosis patients: a single-center experience and assessment of quality of life

Publisher

England: BioMed Central

Journal title

Italian journal of pediatrics, 2025-03, Vol.51 (1), p.83-13, Article 83

Language

English

Formats

Publication information

Publisher

England: BioMed Central

More information

Scope and Contents

Contents

Allogeneic hematopoietic stem cell transplantation (HSCT) has proven to be a viable treatment option for patients with mucopolysaccharidoses (MPS). We investigate the efficacy and improvements in the quality of life of HSCT in pediatric patients with MPS.
A retrospective analysis of transplantation data from 46 cases of MPS from a single institu...

Alternative Titles

Full title

Allogeneic hematopoietic stem cell transplantation for mucopolysaccharidosis patients: a single-center experience and assessment of quality of life

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_ea00c93eae8b44a1bbe954d142586668

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ea00c93eae8b44a1bbe954d142586668

Other Identifiers

ISSN

1824-7288,1720-8424

E-ISSN

1824-7288

DOI

10.1186/s13052-025-01919-7

How to access this item